TY - JOUR
T1 - The biocompatibility and the metabolic impact of thermoresponsive, bile acid-based nanogels on auditory and macrophage cell lines
AU - Kovacevic, Bozica
AU - Raj Wagle, Susbin
AU - Mihaela Ionescu, Corina
AU - Foster, Thomas
AU - Đanić, Maja
AU - Mikov, Momir
AU - Mooranian, Armin
AU - Al-Salami, Hani
N1 - Funding Information:
The work is partially supported by the European Union Horizon 2020 research project and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 872370 . Curtin Faculty ORS-WAHAI Consortium and the Australian National Health and Medical Research ( APP9000597 ).
Funding Information:
The authors would like to acknowledge the Australian Postgraduate Award (APA) and Curtin Research Scholarship (CRS). The authors acknowledge the Microscopy and Microanalysis Facility at Curtin University. The authors acknowledge The Ian Potter Foundation for funding support for equipment.
Funding Information:
The work is partially supported by the European Union Horizon 2020 research project and innovation programunder the Marie Skłodowska-Curie Grant Agreement No. 872370. Curtin Faculty ORS-WAHAI Consortium and the Australian National Health and Medical Research (APP9000597).
Publisher Copyright:
© 2023
PY - 2023/9
Y1 - 2023/9
N2 - Deoxycholic acid (DCA), lithocholic acid (LCA), and ursodeoxycholic acid (UDCA) are bile acids that may serve as permeation enhancers when incorporated within the nanogel matrix for drug delivery in the inner ear. In this study, thermoresponsive nanogels were formulated with DCA, LCA and UDCA and their rheological properties and biocompatibility were assessed. The impact of nanogel on cellular viability was evaluated via cell viability assay, the impact of nanogels on cellular bioenergetic parameters was estimated by Seahorse mito-stress test and glycolysis-stress test, while the presence of intracellular free radicals was assessed by reactive oxygen species assay. Nanogels showed a high level of biocompatibility after 24-hour exposure to auditory and macrophage cell lines, with minimal cytotoxicity compared to untreated control. Incubation with nanogels did not alter cellular respiration and glycolysis of the auditory cell line but showed possible mitochondrial dysfunction in macrophages, suggesting tissue-dependent effects of bile acids. Bile acid-nanogels had minimal impact on intracellular reactive oxygen species, with LCA demonstrating the most pro-oxidative behaviour. This study suggests that thermoresponsive nanogels with bile acid, particularly DCA and UDCA, may be promising candidates for inner ear drug delivery.
AB - Deoxycholic acid (DCA), lithocholic acid (LCA), and ursodeoxycholic acid (UDCA) are bile acids that may serve as permeation enhancers when incorporated within the nanogel matrix for drug delivery in the inner ear. In this study, thermoresponsive nanogels were formulated with DCA, LCA and UDCA and their rheological properties and biocompatibility were assessed. The impact of nanogel on cellular viability was evaluated via cell viability assay, the impact of nanogels on cellular bioenergetic parameters was estimated by Seahorse mito-stress test and glycolysis-stress test, while the presence of intracellular free radicals was assessed by reactive oxygen species assay. Nanogels showed a high level of biocompatibility after 24-hour exposure to auditory and macrophage cell lines, with minimal cytotoxicity compared to untreated control. Incubation with nanogels did not alter cellular respiration and glycolysis of the auditory cell line but showed possible mitochondrial dysfunction in macrophages, suggesting tissue-dependent effects of bile acids. Bile acid-nanogels had minimal impact on intracellular reactive oxygen species, with LCA demonstrating the most pro-oxidative behaviour. This study suggests that thermoresponsive nanogels with bile acid, particularly DCA and UDCA, may be promising candidates for inner ear drug delivery.
KW - Bile acid
KW - Biocompatibility
KW - Bioenergetics
KW - HEI OC-1
KW - Nanogel
KW - Poloxamer 407
KW - RAW264.7
KW - Thermoresponsive hydrogel
UR - http://www.scopus.com/inward/record.url?scp=85167827309&partnerID=8YFLogxK
U2 - 10.1016/j.ejpb.2023.08.003
DO - 10.1016/j.ejpb.2023.08.003
M3 - Article
C2 - 37562725
AN - SCOPUS:85167827309
SN - 0939-6411
VL - 190
SP - 248
EP - 257
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
ER -